Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure...
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study
About this item
Full title
Author / Creator
Chang, Li-Jun , Hao, Chun-Qiu , Rao, Gui-Rong , Xu, Lin-Li , Li, Jing , Cheng, Yan , Zheng, Li-Jun , Wu, Cun-Wen , Chen, Han-Xian , Chen, Ze-Ren , Lian, Jian-Qi , Wu, Shi-Hong , Luo, Li-Min , Zhang, Wei-Lu and Zhang, Ye
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Hepatitis B surface antigen (HBsAg) clearance is an achievable treatment endpoint for chronic hepatitis B virus (HBV)-infected patients. Pegylated interferon-α (PEG-IFN-α) induces higher rate of HBsAg clearance than nucleos(t)ide analogues. However, the influencing factors associated with HBsAg recurrence have not been fully elucidated. The aim of...
Alternative Titles
Full title
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2536149802ab4bb8936bc0016ad246fb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2536149802ab4bb8936bc0016ad246fb
Other Identifiers
ISSN
1743-422X
E-ISSN
1743-422X
DOI
10.1186/s12985-025-02761-3
